glp-1 vs sglt2 weight loss Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity | Drugs Frontiers | A decade of

While all GLP-1 medications may promote some weight loss, three drugs are specifically indicated for chronic weight management: Zepbound (tirzepatide) Wegovy (semaglutide) Saxenda (liraglutide) Multiple clinical trials have found that each of these medications can help people lose 5%-20% or more of their body weight though research suggests that some may be more effective than others

Whether you're considering Wegovy, Zepbound, Ozempic, Mounjaro, bariatric surgery, or the Medicare GLP-1 Bridge Program, our insurance specialists are here to help you understand your coverage before treatment begins

Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis

Consistent physical activity and a balanced diet help manage appetite, increase energy expenditure, and support metabolic health